221 related articles for article (PubMed ID: 36814242)
1. Expression of EMT-related genes in lymph node metastasis in endometrial cancer: a TCGA-based study.
Li H; Wang J; Li L; Zhao L; Wang Z
World J Surg Oncol; 2023 Feb; 21(1):55. PubMed ID: 36814242
[TBL] [Abstract][Full Text] [Related]
2. Establishing a Prognostic Signature Based on Epithelial-Mesenchymal Transition-Related Genes for Endometrial Cancer Patients.
Liu J; Cui G; Shen S; Gao F; Zhu H; Xu Y
Front Immunol; 2021; 12():805883. PubMed ID: 35095892
[TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome score as an indicator in a predictive nomogram for lymph node metastasis in endometrial cancer.
Feng X; Li XC; Yang X; Cheng Y; Dong YY; Wang JY; Zhou JY; Wang JL
BMC Cancer; 2023 Jul; 23(1):622. PubMed ID: 37403054
[TBL] [Abstract][Full Text] [Related]
4. An Epithelial-Mesenchymal Transition (EMT) Preoperative Nomogram for Prediction of Lymph Node Metastasis in Bladder Cancer (BLCA).
Cao R; Ma B; Wang G; Xiong Y; Tian Y; Yuan L
Dis Markers; 2020; 2020():8833972. PubMed ID: 33204364
[TBL] [Abstract][Full Text] [Related]
5. Endometrial carcinoma molecular subtype correlates with the presence of lymph node metastases.
Jamieson A; Thompson EF; Huvila J; Leung S; Lum A; Morin C; Ennour-Idrissi K; Sebastianelli A; Renaud MC; Gregoire J; Huntsman DG; Gilks CB; Plante M; Grondin K; McAlpine JN
Gynecol Oncol; 2022 May; 165(2):376-384. PubMed ID: 35504673
[TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of aortic lymph node metastasis in endometrial cancer: Potential implications for selective aortic lymph node assessment.
Cosgrove CM; Cohn DE; Rhoades J; Felix AS
Gynecol Oncol; 2019 Jun; 153(3):505-510. PubMed ID: 30935714
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for pelvic and para-aortic lymph node metastasis in non-endometrioid endometrial cancer.
Sun Y; Wang Y; Cheng X; Wu W; Liu Q; Chen X; Ren F
Eur J Surg Oncol; 2024 Apr; 50(4):108260. PubMed ID: 38484492
[TBL] [Abstract][Full Text] [Related]
8. [Clinical analysis on the lymph nodes metastasis characters and their relation with the prognosis of the endometrial carcinoma patients].
Wang ZQ; Zhang Y; Wang JL; Shen DH; Zhao X; Yao YY; Bai Y; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2011 Jun; 46(6):435-40. PubMed ID: 21781585
[TBL] [Abstract][Full Text] [Related]
9. An EMT-related genes signature as a prognostic biomarker for patients with endometrial cancer.
Yu Y; Zhang Y; Li Z; Dong Y; Huang H; Yang B; Zhao E; Chen Y; Yang L; Lu J; Qiu F
BMC Cancer; 2023 Sep; 23(1):879. PubMed ID: 37723477
[TBL] [Abstract][Full Text] [Related]
10. A nomogram prediction model for lymph node metastasis in endometrial cancer patients.
Wang Z; Zhang S; Ma Y; Li W; Tian J; Liu T
BMC Cancer; 2021 Jun; 21(1):748. PubMed ID: 34187416
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for paraaortic lymph node metastasis in endometrial cancer.
Sari ME; Yalcin İ; Sahin H; Meydanli MM; Gungor T
Int J Clin Oncol; 2017 Oct; 22(5):937-944. PubMed ID: 28523533
[TBL] [Abstract][Full Text] [Related]
12. A preoperative risk-scoring system to predict lymph node metastasis in endometrial cancer and stratify patients for lymphadenectomy.
Imai K; Kato H; Katayama K; Nakanishi K; Kawano A; Iura A; Konnai K; Onose R; Hirahara F; Miyagi E
Gynecol Oncol; 2016 Aug; 142(2):273-7. PubMed ID: 27268220
[TBL] [Abstract][Full Text] [Related]
13. A novel multivariable prediction model for lymphatic dissemination in endometrioid endometrial cancer: The lymph node Metastasis Risk Index.
Meydanli MM; Aslan K; Oz M; Muftuoglu KH; Yalcin I; Engin-Ustun Y
Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():310-315. PubMed ID: 31377459
[TBL] [Abstract][Full Text] [Related]
14. Nomogram with potential clinical use to predict lymph node metastasis in endometrial cancer patients diagnosed incidentally by postoperative pathological assessment.
Taşkın S; Şükür YE; Varlı B; Koyuncu K; Seval MM; Ateş C; Yüksel S; Güngör M; Ortaç F
Arch Gynecol Obstet; 2017 Oct; 296(4):803-809. PubMed ID: 28762064
[TBL] [Abstract][Full Text] [Related]
15. Lymph node metastasis and pattern of recurrence in clinically early stage endometrial cancer with positive lymphovascular space invasion.
Mahdi H; Jernigan A; Nutter B; Michener C; Rose PG
J Gynecol Oncol; 2015 Jul; 26(3):208-13. PubMed ID: 25686395
[TBL] [Abstract][Full Text] [Related]
16. A Comprehensive Nomogram Combining CT Imaging with Clinical Features for Prediction of Lymph Node Metastasis in Stage I-IIIB Non-small Cell Lung Cancer.
Zheng X; Shao J; Zhou L; Wang L; Ge Y; Wang G; Feng F
Ther Innov Regul Sci; 2022 Jan; 56(1):155-167. PubMed ID: 34699046
[TBL] [Abstract][Full Text] [Related]
17. Construction and Validation of a Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Gastric Cancer.
Li S; Zhao Z; Yang H; Wang D; Sun W; Li S; Zhang Z; Fu W
Cancer Control; 2021; 28():10732748211027160. PubMed ID: 34155937
[TBL] [Abstract][Full Text] [Related]
18. Prospective assessment of the prevalence of pelvic, paraaortic and high paraaortic lymph node metastasis in endometrial cancer.
Kumar S; Podratz KC; Bakkum-Gamez JN; Dowdy SC; Weaver AL; McGree ME; Cliby WA; Keeney GL; Thomas G; Mariani A
Gynecol Oncol; 2014 Jan; 132(1):38-43. PubMed ID: 24120926
[TBL] [Abstract][Full Text] [Related]
19. Establishment and evaluation of a risk-scoring system for lymph node metastasis in early-stage endometrial carcinoma: Achieving preoperative risk stratification.
Zhang Y; Zhao W; Chen Z; Zhao X; Ren P; Zhu M
J Obstet Gynaecol Res; 2020 Nov; 46(11):2305-2313. PubMed ID: 32844525
[TBL] [Abstract][Full Text] [Related]
20. Systematic pelvic and paraaortic lymphadenectomy in early high-risk or advanced endometrial cancer.
Fotopoulou C; El-Balat A; du Bois A; Sehouli J; Harter P; Muallem MZ; Krätschell RW; Traut A; Heitz F
Arch Gynecol Obstet; 2015 Dec; 292(6):1321-7. PubMed ID: 25990476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
